DIREVO
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

DIREVO Trademark

Serial Number: 76182408 • Registration: 2796549

DIREVO is a trademark filed by BAYER SCHERING PHARMA AKTIENGESELLSCHAFT on December 18, 2000. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (240 trademarks)

MULLERSTRASSE 178
BERLIN 13353 , DE

Entity Type: 07

BAYER PHARMA AKTIENGESELLSCHAFT (106 trademarks)

MUELLERSTRASSE 178
BERLIN 13353 , DE

Entity Type: 99

Direvo BioTech AG (8 trademarks)

Nattermannallee 1
D-50829 Koln , DE

Entity Type: 03

Trademark Details

Filing Date

December 18, 2000

Registration Date

December 23, 2003

Published for Opposition

September 30, 2003

Cancellation Date

July 25, 2014

Goods & Services

[ Scientific apparatus and laboratory instruments, namely, microscopes, and pipettes, microplate readers, sterilizers, incubators, gas chromatography apparatus, namely, automated glass tubes designed to suction fluids, automated liquid handling apparatus; laboratory glassware, namely, glass slides; laboratory equipment, namely, sample carriers used for the development, preparations and detection of biologically active substances, namely, proteins and nucleic acids; laboratory equipment, namely, fermenters; laboratory apparatus, namely, dispensers for low volume dispensing and ultra high throughput screening (UHTS) ]

[ Pharmaceutical preparations for the treatment of diseases, especially infectious diseases, hereditary diseases, metabolic diseases, stroke and cardiac diseases, allergic diseases, angina, diabetes, insomnia, pharmaceutical preparations, namely, analgesics, anesthtics, anti-tumor agents, for the treatment of adipoe; veterinary preparations for the treatment of diseases, namely, infectious diseases, metabolic diseases, and allergic diseases, veterinary preparations, namely, analgesics, anesthetics, and anti-tumor agents; veterinary vaccines for bovine, sheep, horse, pork, poultry, and fish; sanitary preparations, namely, bactericides, algaecides, germicides, insecticides, enzymes, and fungicides; diagnostic preparations, namely, proteins and nucleic acids for clinical and medical laboratory use; clinical medical diagnostic reagents, namely, proteins and nucleic acids; medical diagnostic reagents; kits comprising of reagents, namely, proteins, nucleic acids, enzymes, buffers; kits comprising of reagents, namely, proteins, nucleic acids, enzymes, buffers, sample plates, disposable tubes, and vessels for molecular-biological medical laboratory use and medical diagnostics ]

[ All purpose cleaning preparations, namely, proteins or nucleic acids specifically enzymes or ribozymes for use in chemical manufacturing industry, car manufacturing industry, dental industry, and other commodities, namely, for use in the personal manufacturing industry, cosmetics manufacturing industry, detergent additive manufacturing industry, and technical enzyme manufacturing industry ]

Chemicals, namely, proteins or nucleic acids including enzymes or ribozymes for use in the manufacture of fine and/or bulk chemicals, pharmaceuticals, [ feed, food, plants, adhesives, detergents, commodities, fabrics, fuel, varnish, paints, plastics, paper, leather, wood, glassware, resins, rubber, or other performance materials; ] catalysts, namely, proteins for nucleic acids specifically enzymes or ribozymes for use in the manufacture of industrial chemicals; chemicals, namely, proteins or nucleic acids specifically enzymes or ribozymes for use in research and development in the fine and/or bulk chemical industry, pharmaceutical industry, [ life sciences, and in the manufacture of animal feed, food, adhesives, detergents, commodities, fabrics, fuel, varnish, paints, plastics, paper, leather, wood, glassware, resins, and the processing of plants and rubber; ] reagents, namely, proteins or nucleic acids for scientific and medical research use, diagnostic preparations for scientific and research use; [ electrophoresis gels ]

Technical consultation and research in the field of molecular biology

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jul 25, 2014 CAEX
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 25, 2013 ASGN
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 12, 2010 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 12, 2010 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jun 23, 2010 815F
TEAS SECTION 8 & 15 RECEIVED
Jun 23, 2010 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 16, 2009 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2009 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2009 REAP
CASE FILE IN TICRS
Jun 1, 2007 CFIT
REVIEW OF CORRESPONDENCE COMPLETE
Sep 1, 2006 CORV
PAPER RECEIVED
Aug 21, 2006 MAIL
REGISTERED-PRINCIPAL REGISTER
Dec 23, 2003 R.PR
PUBLISHED FOR OPPOSITION
Sep 30, 2003 PUBO
NOTICE OF PUBLICATION
Sep 10, 2003 NPUB
PAPER RECEIVED
May 5, 2003 MAIL
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2003 CNSA
ASSIGNED TO EXAMINER
Mar 4, 2003 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2003 CRFA
PAPER RECEIVED
Jan 22, 2003 MAIL
FINAL REFUSAL MAILED
Jul 16, 2002 CNFR
LETTER OF SUSPENSION MAILED
Feb 25, 2002 CNSL
Sec. 1(B) CLAIM DELETED
Feb 12, 2002 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2001 CRFA
NON-FINAL ACTION MAILED
May 8, 2001 CNRT
ASSIGNED TO EXAMINER
Apr 12, 2001 DOCK